Insider · CIK 0002075230
Barbara Harlin Bispham
Files at CBIO (CRESCENT BIOPHARMA, INC.). First filing Sep 18, 2026, latest Sep 18, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CBIO: CRESCENT BIOPHARMA, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | CRESCENT BIOPHARMA, INC. | $11k 620 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | CBIO CRESCENT BIOPHARMA, INC. | SOpen-market sale Ordinary Shares10b5-1 | -620 | $17.90 | $11k | 18,710 | 24 d ago |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | AGrant or award Ordinary Shares | +12,422 | - | - | 12,422 | Dec 17, 2025 |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | AGrant or award Ordinary Shares | +6,000 | - | - | 18,422 | Dec 17, 2025 |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | AGrant or award Stock Option (Right to Buy)derivative | +72,185 | $0.00 | $0 | 72,185 | Dec 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.